<html xmlns="http://www.w3.org/1999/xhtml" xmlns="http://www.w3.org/1999/xhtml">
 <head xmlns="http://www.w3.org/1999/xhtml">
 <title xmlns="http://www.w3.org/1999/xhtml"></title>
 </head>
 <body xmlns="http://www.w3.org/1999/xhtml">
 
 On May 24, 2017, the US FDA published the executive summary and research 
 summaries supporting Philip Morris International Inc.'s (PMI) 
 (NYSE/Euronext Paris: PM) Modified Risk Tobacco Product (MRTP) 
 application for the company's EHTP. In doing so, the agency announced 
 that it will publish a notice in the Federal Register establishing a 
 formal docket for public comments on PMI's application at a later date.
 
 
 PMI submitted the application to the FDA on December 5, 2016.
 
 
 Publication of PMI's summaries initiates a substantive scientific review 
 process by the FDA's Center for Tobacco Products.
 
 
 The FDA has made PMI's application summaries publicly available <a xmlns="http://www.w3.org/1999/xhtml" href="http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.fda.gov%2FTobaccoProducts%2FLabeling%2FMarketingandAdvertising%2Fucm546281.htm&amp;esheet=51565248&amp;newsitemid=20170525005620&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=15fd2aa9df18d4888bd930ac20715153" rel="nofollow" rel="nofollow">here</a>. 
 The agency will publish additional modules of PMI's MRTP application on 
 a rolling basis. The FDA has established a one-year timetable for 
 reviewing MRTP applications. However, that timing is non-binding.
 
 
 "We welcome FDA and public review of the comprehensive scientific 
 evidence package that we submitted to the agency through its MRTP 
 application process," said Dr. Moira Gilchrist, PMI Vice President 
 Corporate Affairs of Reduced-Risk Products. "PMI's application 
 demonstrates our commitment to develop innovative, smoke-free 
 technologies that can ultimately replace combustible cigarettes to the 
 benefit of smokers, public health and society at large."
 
 
 Interested members of the scientific and public health communities can 
 find more information on PMI's EHTP at: <a xmlns="http://www.w3.org/1999/xhtml" href="http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fpmiscienceusa.com%2F&amp;esheet=51565248&amp;newsitemid=20170525005620&amp;lan=en-US&amp;anchor=PMIScienceUSA.com&amp;index=2&amp;md5=2950910139236ddd4b22d5c175c11ab0" rel="nofollow" rel="nofollow">PMIScienceUSA.com</a>.
 
 
 About Philip Morris International Inc. ("PMI")
 
 
 PMI is the world's leading international tobacco company, with six of 
 the world&#39;s top 15 international brands and products sold in more than 
 180 markets. In addition to the manufacture and sale of cigarettes, 
 including Marlboro, the number one global cigarette brand, 
 and other tobacco products, PMI is engaged in the development and 
 commercialization of reduced-risk products ("RRPs"). RRPs is the term 
 PMI uses to refer to products that present, are likely to present, or 
 have the potential to present less risk of harm to smokers who switch to 
 these products versus continued smoking. Through multidisciplinary 
 capabilities in product development, state-of-the-art facilities, and 
 industry-leading scientific substantiation, PMI aims to provide an RRP 
 portfolio that meets a broad spectrum of adult smoker preferences and 
 rigorous regulatory requirements. For more information, see <a xmlns="http://www.w3.org/1999/xhtml" href="http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.pmi.com&amp;esheet=51565248&amp;newsitemid=20170525005620&amp;lan=en-US&amp;anchor=www.pmi.com&amp;index=3&amp;md5=232c6f2afac8d5de5f501b68dc8e7411" rel="nofollow" rel="nofollow">www.pmi.com</a> and <a xmlns="http://www.w3.org/1999/xhtml" href="http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.pmiscience.com&amp;esheet=51565248&amp;newsitemid=20170525005620&amp;lan=en-US&amp;anchor=www.pmiscience.com&amp;index=4&amp;md5=defece107815bd52b8072c8666f66f9c" rel="nofollow" rel="nofollow">www.pmiscience.com</a>.
 
 
 
 <img xmlns="http://www.w3.org/1999/xhtml" alt="" src="http://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20170525005620r1&amp;sid=benz2&amp;distro=nx&amp;lang=en"></img>View source version on businesswire.com: <a xmlns="http://www.w3.org/1999/xhtml" href="http://www.businesswire.com/news/home/20170525005620/en/" rel="nofollow" rel="nofollow">http://www.businesswire.com/news/home/20170525005620/en/</a></body></html>

Press Releases

US Food and Drug Administration (FDA) Begins Scientific Review of Philip Morris International's Modified Risk Tobacco Product Application for its Electronically Heated Tobacco Product (EHTP) - Philip Morris Intl (NYSE:PM)

Philip Morris Intl

US Food and Drug Administration (FDA) Begins Scientific Review of Philip Morris International's Modified Risk Tobacco Product Application for its Electronically Heated Tobacco Product (EHTP)

ADTN


ADTRAN Holdings, Inc. (NASDAQ:ADTN, FSE: QH9)), announced today that Company representatives will meet with investors at the Germany Spring Conference 2024 – Equity Forum in Frankfurt Germany May 13-15, 2024.


ADTRAN

ADTRAN Holdings, Inc. to Meet with Investors at the German Spring Conference 2024 – Equity Forum on May 13-15, 2023

INTC

The Law Offices of Frank R. Cruz Announces Investigation of Intel Corporation (INTC) on Behalf of Investors


GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D., to serve as advisors to ReNAgade


Additional investment strengthens ReNAgade&#39;s delivery platform with unique conjugation platform based on novel

ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology

SMAL


The Board of Directors of Summit Bancshares, Inc., at a meeting held on April 17, 2024, in recognition of the bank&#39;s 42nd year in business, declared a one-time special cash dividend of $0.42 per share, payable on June

Summit Bancshares, Inc. Announces a Special Dividend


The Board of Directors of Summit Bancshares Inc., at a meeting held on April 17, 2024, declared a quarterly cash dividend of $0.11 per share, payable on June 14, 2024, to holders of record as of the close of business on

Summit Bancshares, Inc. Announces 1st Quarter Cash Dividend

FULT


Fulton doubles regional presence while providing stability to customers


Fulton Financial Corporation (NASDAQ:FULT) (the &#34;Corporation&#34;) today announced that its bank subsidiary, Fulton Bank, N.A. (&#34;Fulton&#34;), has

Fulton Financial Corporation Acquires Substantially All of the Assets and Assumes Substantially All of the Deposits of Republic First Bank From the FDIC